T. Muayqil, G. Gronseth and R. Camicioli, “EvidenceBased Guideline: Diagnostic Accuracy of CSF 14-3-3 Protein in Sporadic Creutzfeldt-Jakob Disease: Report of the Guideline Development Subcommittee of the American Academy of Neurology,” Neurology, Vol. 79, No. 14, 2012, pp. 1499-1506. doi:10.1212/WNL.0b013e31826d5fc3

has been cited by the following article:

• TITLE: Sporadic Creutzfeldt-Jakob Disease Presenting with Visual Disturbance—A Case Report in China

  AUTHORS: Guohong Tian, Lin Sun, Yunhong He, Xiaojun Zhang

  KEYWORDS: Creutzfeldt-Jakob Disease; Visual Disturbance; Heidenhain Variant; Diffusion Weighted Imaging

  JOURNAL NAME: International Journal of Clinical Medicine, Vol.4 No.7, July 4, 2013

  ABSTRACT: Creutzfeldt-Jakob disease (CJD) is a rare but fatal neurodegenerative prion disease. Classic CJD comprises a clinical triad of rapidly progressive dementia, myoclonus, and EEG abnormality. At initial presentation, this classic triad is present only in a minority of cases. Visual impairment is one of the predominant manifestations in the course of CJD, especially in Heidenhain variant phenotype. We reported a case presenting with progressive blurred vision, along with other neurological symptoms, who diagnosed as sporadic CJD with cortical blindness in China.